{"id":"https://openalex.org/W2997572052","doi":"https://doi.org/10.1080/13543784.2020.1708898","title":"Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis","display_name":"Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-03","ids":{"openalex":"https://openalex.org/W2997572052","doi":"https://doi.org/10.1080/13543784.2020.1708898","mag":"2997572052","pmid":"https://pubmed.ncbi.nlm.nih.gov/31899984"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2020.1708898","doi":"https://doi.org/10.1080/13543784.2020.1708898","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1708898","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1708898?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2997572052"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1708898?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006566187","display_name":"Cristy R.C. Verzijl","orcid":"https://orcid.org/0000-0002-8359-0370","observed_orcids":["https://orcid.org/0000-0002-8359-0370"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristy R.C. Verzijl","raw_affiliation_strings":["Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046477548","display_name":"Ivo P. van de Peppel","orcid":"https://orcid.org/0000-0002-6268-3404","observed_orcids":["https://orcid.org/0000-0002-6268-3404"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ivo P. Van De Peppel","raw_affiliation_strings":["Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046770749","display_name":"Dicky Struik","orcid":"https://orcid.org/0009-0004-0143-0157","observed_orcids":["https://orcid.org/0009-0004-0143-0157"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dicky Struik","raw_affiliation_strings":["Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016852056","display_name":"Johan W. Jonker","orcid":"https://orcid.org/0000-0002-3919-5437","observed_orcids":["https://orcid.org/0000-0002-3919-5437"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Johan W. Jonker","raw_affiliation_strings":["Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-3919-5437","affiliations":[{"raw_affiliation_string":"Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016852056"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":1.1428,"has_fulltext":true,"cited_by_count":74,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77873563,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"29","issue":"2","first_page":"125","last_page":"133"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf21","display_name":"FGF21","score":0.8790000081062317},{"id":"https://openalex.org/keywords/fgf21-analogues","display_name":"FGF21 analogues","score":0.9010000228881836},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.6880000233650208},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.7789999842643738},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5879999995231628},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8134244680404663},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.756197452545166},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.7550760507583618},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.6794192790985107},{"id":"https://openalex.org/C106646824","wikidata":"https://www.wikidata.org/wiki/Q5425475","display_name":"FGF21","level":4,"score":0.6402277946472168},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.6112256050109863},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.5799345970153809},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5303897261619568},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4418976306915283},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.4202059507369995},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4020949602127075},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23900091648101807},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.06090465188026428},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/13543784.2020.1708898","doi":"https://doi.org/10.1080/13543784.2020.1708898","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1708898","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1708898?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pure.rug.nl:openaire/a8747d25-31f5-42ba-a5d5-37e9fdbc6066","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/a8747d25-31f5-42ba-a5d5-37e9fdbc6066","pdf_url":"https://research.rug.nl/files/111582414/Pegbelfermin_BMS_986036_an_investigational_PEGylated_fibroblast_growth_factor_21_analogue_for_the_treatment_of_nonalcoholic_steatohepatitis.pdf","source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Verzijl, C R C, Van De Peppel, I P, Struik, D & Jonker, J W 2020, 'Pegbelfermin (BMS-986036) : an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis', Expert opinion on investigational drugs, vol. 29, no. 2, pp. 1-9. https://doi.org/10.1080/13543784.2020.1708898","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:31899984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31899984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/a8747d25-31f5-42ba-a5d5-37e9fdbc6066","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/a8747d25-31f5-42ba-a5d5-37e9fdbc6066","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert opinion on investigational drugs, 29(2), 1 - 9. Taylor &amp; Francis Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1080/13543784.2020.1708898","doi":"https://doi.org/10.1080/13543784.2020.1708898","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1708898","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1708898?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2997572052.pdf","grobid_xml":"https://content.openalex.org/works/W2997572052.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W1522113235","https://openalex.org/W1966181749","https://openalex.org/W1966549856","https://openalex.org/W1984603193","https://openalex.org/W1991380553","https://openalex.org/W2000665430","https://openalex.org/W2003495422","https://openalex.org/W2005063766","https://openalex.org/W2017511982","https://openalex.org/W2021000378","https://openalex.org/W2026450587","https://openalex.org/W2043531340","https://openalex.org/W2052061962","https://openalex.org/W2054195724","https://openalex.org/W2062842771","https://openalex.org/W2084948079","https://openalex.org/W2091106363","https://openalex.org/W2091857952","https://openalex.org/W2106768039","https://openalex.org/W2110534048","https://openalex.org/W2111160264","https://openalex.org/W2114836473","https://openalex.org/W2116935356","https://openalex.org/W2119351413","https://openalex.org/W2122860085","https://openalex.org/W2125963555","https://openalex.org/W2130700195","https://openalex.org/W2132596222","https://openalex.org/W2147734839","https://openalex.org/W2152524374","https://openalex.org/W2156492800","https://openalex.org/W2157338541","https://openalex.org/W2166264058","https://openalex.org/W2168118376","https://openalex.org/W2214871873","https://openalex.org/W2215535790","https://openalex.org/W2234735029","https://openalex.org/W2294754341","https://openalex.org/W2415314033","https://openalex.org/W2480504285","https://openalex.org/W2519114186","https://openalex.org/W2602328838","https://openalex.org/W2621364880","https://openalex.org/W2734724639","https://openalex.org/W2762869502","https://openalex.org/W2770129291","https://openalex.org/W2773466959","https://openalex.org/W2785779482","https://openalex.org/W2792597070","https://openalex.org/W2793275191","https://openalex.org/W2796661731","https://openalex.org/W2800376869","https://openalex.org/W2808302800","https://openalex.org/W2809966515","https://openalex.org/W2810423511","https://openalex.org/W2881519211","https://openalex.org/W2884076688","https://openalex.org/W2888859009","https://openalex.org/W2899389750","https://openalex.org/W2900274665","https://openalex.org/W2903736473","https://openalex.org/W2905440332","https://openalex.org/W2907864204","https://openalex.org/W2909812323","https://openalex.org/W2918007312","https://openalex.org/W2922706953","https://openalex.org/W2955603751","https://openalex.org/W2981261474"],"related_works":["https://openalex.org/W4366779252","https://openalex.org/W2905440332","https://openalex.org/W3135465578","https://openalex.org/W4366779384","https://openalex.org/W4318542444","https://openalex.org/W2933286047","https://openalex.org/W4388465036","https://openalex.org/W7114799129","https://openalex.org/W3003075915","https://openalex.org/W4411932974"],"abstract_inverted_index":{"Introduction:":[0],"Nonalcoholic":[1],"fatty":[2,35],"liver":[3,10,52,60,190],"disease":[4,11,53],"(NAFLD)":[5],"is":[6,14,78,88,130,138,156],"the":[7,44,92,99,116],"most":[8],"common":[9],"worldwide":[12],"and":[13,19,59,67,103,112],"strongly":[15],"associated":[16],"with":[17,106,142],"obesity":[18],"insulin":[20],"resistance.":[21],"NAFLD":[22],"refers":[23],"to":[24,38,73,158],"a":[25,79,139,165],"spectrum":[26],"of":[27,46,51,94,118],"disorders":[28],"ranging":[29],"from":[30],"asymptomatic":[31],"hepatic":[32],"steatosis":[33],"(nonalcoholic":[34],"liver,":[36],"NAFL)":[37],"nonalcoholic":[39],"steatohepatitis":[40],"(NASH),":[41],"which":[42],"increases":[43],"risk":[45],"developing":[47],"more":[48,154],"severe":[49],"forms":[50],"such":[54,188],"as":[55,189],"progressive":[56],"fibrosis,":[57],"cirrhosis,":[58],"cancer.":[61],"Currently,":[62],"there":[63,129],"are":[64,151,196],"no":[65,122],"food":[66],"drug":[68],"administration":[69],"(FDA)":[70],"approved":[71,124],"drugs":[72],"treat":[74],"NASH.":[75],"Pegbelfermin":[76,137],"(BMS-986036)":[77],"PEGylated":[80],"fibroblast":[81],"growth":[82],"factor":[83],"21":[84],"(FGF21)":[85],"analogue":[86],"that":[87,109],"under":[89],"investigation":[90],"for":[91,127,134,198],"treatment":[93,117,141],"NASH.Areas":[95],"covered:":[96],"We":[97],"reviewed":[98],"(pre)clinical":[100],"pegbelfermin":[101,169],"studies":[102,108],"compared":[104],"these":[105],"other":[107],"assessed":[110],"FGF21":[111,113],"analogues":[114],"in":[115,174],"NASH.Expert":[119],"opinion:":[120],"With":[121],"FDA":[123],"treatments":[125],"available":[126],"NASH,":[128],"an":[131],"urgent":[132],"need":[133],"novel":[135],"therapies.":[136],"systemic":[140],"pleiotropic":[143],"effects":[144,150],"on":[145,185],"various":[146],"tissues.":[147],"Short-term":[148],"adverse":[149],"limited,":[152],"but":[153],"research":[155],"required":[157,197],"study":[159],"potential":[160],"long-term":[161,183],"safety":[162],"issues.":[163],"In":[164],"phase":[166],"2a":[167],"trial,":[168],"has":[170],"shown":[171],"promising":[172],"improvements":[173],"several":[175],"NASH":[176],"related":[177],"outcomes.":[178],"However,":[179],"clinical":[180],"trials":[181],"demonstrating":[182],"benefits":[184],"hard":[186],"outcomes":[187],"histology,":[191],"cirrhosis":[192],"development,":[193],"or":[194],"survival":[195],"further":[199],"validation.":[200]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2997572052","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":7},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2020-01-10T00:00:00"}
